Fisher Asset Management
IMVT icon

Fisher Asset Management’s Immunovant IMVT Stock Holding History

Fisher Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$18.4M Buy
+545,730
New +$21.5M 0.01% 347

Other funds holding IMVT

Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Fisher Asset Management's IMVT Position: Q3 2026 in Review

Fisher Asset Management opened a new position in Immunovant (IMVT) in Q3 2026: 545,730 shares worth $18.4M. The stake represents 0.01% of the portfolio and ranks #347 among its holdings.

72 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • Fisher Asset Management held 545,730 shares of Immunovant worth $18.4M as of Q3 2026.
  • Immunovant was a new Fisher Asset Management position in Q3 2026.
  • Immunovant made up 0.01% of Fisher Asset Management's portfolio in Q3 2026, its #347 holding.
  • 72 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on Fisher Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.